You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CLINICAL TRIALS PROFILE FOR LOVASTATIN


✉ Email this page to a colleague

« Back to Dashboard


505(b)(2) Clinical Trials for lovastatin

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
OTC NCT00092846 ↗ A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED) Completed Merck Sharp & Dohme Corp. Phase 3 2002-12-04 The purpose of this study is to evaluate the ability of patients with intermediate risk of heart disease to appropriately use a Self-Management System.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for lovastatin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000463 ↗ Post Coronary Artery Bypass Graft (CABG) Study Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1987-04-01 To determine the relative effectiveness of moderate versus more aggressive lipid lowering, and of low dose anticoagulation versus placebo, in delaying saphenous vein coronary bypass graft atherosclerosis and preventing occlusion of saphenous grafts of patients with saphenous vein coronary bypass grafts placed 1 to 11 years previously.
NCT00000469 ↗ Asymptomatic Carotid Artery Plaque Study (ACAPS) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 2 1988-05-01 To determine whether warfarin or lovastatin alone or in combination retarded the progression of atherosclerotic plaques in the carotid arteries of high risk individuals with asymptomatic carotid stenosis. Also, to determine if a full scale trial was feasible.
NCT00000477 ↗ Cholesterol Reduction in Seniors Program (CRISP) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 2 1990-07-01 To conduct a pilot study to determine whether lowering elevated serum cholesterol levels with 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG CoA) reductase inhibitors reduced mortality due to the sequelae of atherosclerotic cardiovascular disease in older men and women.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for lovastatin

Condition Name

Condition Name for lovastatin
Intervention Trials
Hypercholesterolemia 7
Cardiovascular Diseases 5
Heart Diseases 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for lovastatin
Intervention Trials
Hypercholesterolemia 9
Cardiovascular Diseases 7
Dyslipidemias 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for lovastatin

Trials by Country

Trials by Country for lovastatin
Location Trials
United States 140
Canada 15
Taiwan 7
Netherlands 4
Korea, Republic of 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for lovastatin
Location Trials
California 17
North Carolina 8
New York 7
Ohio 6
Pennsylvania 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for lovastatin

Clinical Trial Phase

Clinical Trial Phase for lovastatin
Clinical Trial Phase Trials
Phase 4 13
Phase 3 10
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for lovastatin
Clinical Trial Phase Trials
Completed 48
Terminated 10
Unknown status 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for lovastatin

Sponsor Name

Sponsor Name for lovastatin
Sponsor Trials
National Heart, Lung, and Blood Institute (NHLBI) 5
National Taiwan University Hospital 4
University of Iowa 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for lovastatin
Sponsor Trials
Other 88
Industry 27
NIH 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.